Disorders of sexual preference

F5_SEXPREF

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F65 Hospital discharge: ICD-9 — 302[1-2]\|3024\|3028\|3029 Hospital discharge: ICD-8 — 302 Hospital discharge: excluded ICD-8 — 3023 Cause of death: ICD-10 — F65 Cause of death: ICD-9 — 302[1-2]\|3024\|3028\|3029 Cause of death: ICD-8 — 302 Cause of death: excluded ICD-8 — 3023 2 out of 7 registries used, show all original rules.	82
4. Check minimum number of events None	82
5. Include endpoints None	82
6. Filter based on genotype QC (FinnGen only)	82

Control definitions (FinnGen only)

Control exclude: F5_PERSOBEH

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: F63-F69
Name in latin: Perturbationes praeferentiae sexualis

NAME	F5_SEXPREF
CONTROL_EXCLUDE	F5_PERSOBEH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F65
HD_ICD_9	302[1-2]\|3024\|3028\|3029
HD_ICD_8	302
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL	3023
COD_MAINONLY
COD_ICD_10	F65
COD_ICD_9	302[1-2]\|3024\|3028\|3029
COD_ICD_8	302
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL	3023
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Disorders of sexual preference based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	921	154	755
Only index persons	675	116	559
Unadjusted period prevalence (%)
Whole population	0.02	0.00	0.02
Only index persons	0.02	0.00	0.02
Median age at first event (years)
Whole population	31.68	28.72	32.05
Only index persons	29.04	23.76	30.13

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	82	11	71
Unadjusted period prevalence (%)	0.03	0.00	0.03
Median age at first event (years)	32.88	28.29	33.59

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
77: Matched controls
768

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F65.4

ICD-10 Finland

Paedophilia

+∞

17.3

N05AH03

ATC

olanzapine; systemic

44.1

16.7

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

19.9

16.5

30200

ICD-8 Finland

Sexual deviation, Homosexuality

+∞

12.9

30299

ICD-8 Finland

Sexual deviation, Unspecified

+∞

10.7

N03AG01

ATC

valproic acid; systemic, rectal

11.8

9.4

N06AB04

ATC

citalopram; systemic

6.0

9.2

N05AA02

ATC

levomepromazine; systemic

16.8

9.1

N06AB03

ATC

fluoxetine; oral

7.8

9.0

N05AX08

ATC

risperidone; systemic

11.9

7.9

30041

ICD-8 Finland

Neuroses, Depressiva

50.3

7.9

F61.0

ICD-10 Finland

Mixed personality disorders

88.2

7.6

30188

ICD-8 Finland

Personality disorders, Alia definita

+∞

7.4

N05CD07

ATC

temazepam; oral

6.2

7.3

N05AF03

ATC

chlorprothixene; systemic

33.5

7.3

N05AB03

ATC

perphenazine; systemic, rectal

18.8

6.9

N05AX12

ATC

aripiprazole; systemic

18.8

6.9

N05BA04

ATC

oxazepam; oral

4.5

6.8

F29

ICD-10 Finland

Unspecified nonorganic psychosis

16.1

6.6

T36

ICD-10 Finland

Poisoning by systemic antibiotics

10.7

6.6

N05AN01

ATC

lithium; oral

75.9

6.5

N05AD01

ATC

haloperidol; systemic

20.1

6.4

N05AA01

ATC

chlorpromazine; systemic, rectal

29.3

6.4

F65.0

ICD-10 Finland

Fetishism

+∞

6.3

F65.9

ICD-10 Finland

Disorder of sexual preference, unspecified

+∞

6.3

E9509

ICD-8 Finland

Suicide and self-inflicted poisoning by solid or liquid substances, Other and unspecified solid and liquid substances

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

163

3.00

5.41

12.7

5.5

—

(3028707) Methadone [Presence] in Urine by Screen method

9.69

4.38

5.8

2.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

9.42

3.85

27.1

13.3

626.4

620.6

nmol/l

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

9.42

3.85

35.1

18.3

1035.9

888.4

nmol/l

—

(3012544) pH of Venous blood

3.18

3.47

3.9

4.2

—

(3028626) Oxygen [Partial pressure] in Capillary blood

6.26

3.09

14.6

2.6

7.6

8.3

kpa

—

(3011288) Drugs identified in Urine by Screen method

4.99

2.66

6.6

1.9

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

277

2.06

2.61

9.1

8.9

1.2

mmol/l

0.03

234

(3021901) Oxygen saturation in Capillary blood

5.79

2.59

2.5

2.7

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

4.10

2.53

5.8

1.5

—

(3023368) Bacteria identified in Blood by Culture

176

2.11

2.53

4.7

4.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.52

2.34

2.1

1.7

—

(3000764) Benzodiazepines [Presence] in Urine

3.36

2.30

5.2

1.7

—

(3027008) Opiates [Presence] in Urine

3.36

2.30

5.2

1.7

—

(3027944) Amphetamines [Presence] in Urine

3.36

2.30

5.2

1.7

—

(3016879) Cocaine [Presence] in Urine

3.36

2.30

5.2

1.7

—

(3028300) Cannabinoids [Presence] in Urine

3.36

2.30

5.7

1.7

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3.93

2.20

1.1

1.4

—

(1761868) Lipid panel - Serum or Plasma

265

0.43

2.19

5.4

2.8

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2.43

2.08

1.1

2.3

—

(3009508) Creatinine [Moles/volume] in Urine

205

1.92

2.06

3.8

3.1

10.2

8.7

mmol/l

0.48

175

(3021589) Normoblasts [#/volume] in Blood

306

1.85

1.98

14.1

9.3

0.0

e9/l

0.37

249

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2.43

1.96

1.1

2.1

—

(3026008) Bacteria identified in Urine by Culture

131

1.93

1.72

3.2

2.8

—

(3018095) Leukocytes [#/volume] in Urine

225

1.78

1.69

5.6

2.9

166.1

47.5

e6/l

0.68

166

(3000492) Spirometry study

2.23

1.65

1.6

1.4

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

209

1.78

1.64

2.5

1.8

87.0

95.5

pmol/l

0.54

115

(3011397) Hemoglobin [Presence] in Urine by Test strip

125

1.91

1.64

3.5

—

(3000991) Gas panel - Venous blood

2.29

1.52

13.5

8.3

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

2.47

1.48

3.3

4.3

128.1

132.9

g/l

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

105

1.92

1.48

5.7

2.3

0.9

1.1

e6/l

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

2.34

1.46

10.7

2.9

6.1

5.1

kpa

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

3.26

1.46

1.2

1.3

—

(3012516) Albumin [Mass/volume] in Urine

191

1.71

1.39

2.7

3.2

44.8

413.9

mg/l

0.56

131

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2.73

1.39

2.2

1.6

—

(3009261) Glucose [Presence] in Urine by Test strip

302

1.63

1.35

3.3

3.5

0.4

0.0

estimate

—

(3004588) Protein electrophoresis panel - Serum or Plasma

2.50

1.33

1.3

2.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2.89

1.30

1.2

2.4

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1.87

1.29

6.1

2.3

2.5

1.5

e6/l

—

(3052851) Hemolysis interference index of Serum or Plasma

2.73

1.23

2.2

3.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

298

1.59

1.22

4.8

4.5

0.0

estimate

—

(3022621) pH of Urine by Test strip

2.16

1.19

1.6

2.2

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

1.19

0.0

1.4

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.45

1.15

4.7

3.8

47.9

60.8

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

2.30

1.11

3.9

4.6

25.6

24.4

mmol/l

—

(3030467) Casts [#/volume] in Urine by Automated count

193

1.59

1.10

5.3

2.5

0.6

0.3

e6/l

0.43

141

(3009343) pH of Capillary blood

2.07

1.08

11.3

2.9

—

7.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.01

1.06

2.6

1.8

341.0

359.1

nmol/l

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

240

1.55

1.06

5.2

2.7

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.09

1.03

3.3

2.4

1.2

1.6

—

(42870588) Differential panel, method unspecified - Blood

216

1.53

0.98

8.2

5.3

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

137

1.61

0.96

2.5

1.6

0.7

0.8

mg/l

0.36

105

(3004716) Salmonella sp identified in Stool by Organism specific culture

2.32

0.95

2.0

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

645

1.75

0.92

5.5

4.3

6.4

6.1

mmol/l

0.64

586

(3018418) pH of Serum or Plasma

174

1.54

0.91

3.5

3.7

7.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

139

1.58

0.90

9.8

5.2

—

(36304419) Bacteria [Presence] in Urine

184

1.52

0.88

5.4

2.3

—

(3000494) Fungus identified in Specimen by Culture

1.75

0.87

2.1

1.8

—

(3032080) INR in Blood by Coagulation assay

260

1.45

0.83

3.4

7.9

1.2

inr

—

(3001019) Free T4 and TSH panel - Serum or Plasma

0.00

0.80

0.0

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1.82

0.78

1.2

1.6

—

(3022313) Gas panel - Capillary blood

1.82

0.78

16.5

2.9

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

226

1.44

0.77

2.8

2.5

178.8

162.5

ug/l

0.15

209

(3020682) Albumin/Creatinine [Ratio] in Urine

208

1.44

0.76

3.4

4.1

5.0

11.7

mg/mmol

0.94

140

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.87

0.75

1.9

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1.77

0.72

1.3

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

120

1.53

0.72

1.5

1.8

—

(3020891) Body temperature

1.98

0.72

4.2

4.7

—

(3035350) Ketones [Presence] in Urine by Test strip

295

1.39

0.71

3.4

0.0

estimate

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.63

0.70

2.8

1.8

—

(3037467) Urinalysis macro (dipstick) panel - Urine

414

1.38

0.69

5.8

3.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.60

0.61

1.4

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.60

0.61

3.3

1.8

—

(40768800) Prostate Pathology biopsy report

0.00

0.61

0.0

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.50

0.59

1.6

1.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.51

0.57

1.6

2.3

2.4

g/l

0.11

(3022948) Iron [Moles/volume] in Serum or Plasma

100

1.48

0.56

1.7

2.3

11.6

14.1

umol/l

0.70

(3002582) Erythrocytes [#/volume] in Urine

209

1.36

0.56

5.5

2.6

51.0

40.5

e6/l

0.09

157

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

102

1.45

0.51

1.4

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1.46

0.49

1.2

6.9

27.2

iu/ml

—

(3019225) pH of Specimen

1.44

0.46

4.1

3.9

—

(4010399)

1.47

0.44

1.3

1.5

—

(3044889) 12 lead EKG panel

472

1.28

0.44

4.4

3.7

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

256

1.27

0.42

3.4

3.8

38.6

28.0

ng/l

0.20

179

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.41

0.0

1.6

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.7

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

641

1.36

0.41

19.4

11.7

84.8

84.5

ml/min/173m2

0.03

526

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.41

0.0

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.40

0.0

1.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.41

0.40

2.7

3.0

—

(40768804) Tissue Pathology biopsy report

210

0.76

0.40

3.0

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

665

1.36

0.37

19.7

13.4

17.6

24.2

mg/l

1.61

527

(3041096) Erythrocytes [Presence] in Urine by Automated

176

0.75

0.37

3.4

3.0

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1.42

0.36

11.5

14.5

6.3

4.9

kpa

—

(40768797) Stomach Pathology biopsy report

1.38

0.34

1.3

—

(3002256) Pathology report gross observation

0.67

0.27

1.8

1.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.28

0.27

1.7

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

694

1.31

0.26

26.7

15.3

139.1

139.7

mmol/l

1.11

675

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

718

1.31

0.22

14.8

9.7

38.1

30.8

u/l

0.39

694

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

400

0.86

0.22

3.2

4.3

1.6

2.5

ug/l

0.56

362

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

3.0

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

0.00

0.21

0.0

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

1.9

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.21

0.0

1.9

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.21

0.0

1.9

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.21

0.0

2.0

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.00

0.21

0.0

1.2

—

8.3

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.8

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

3.5

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.3

—

606.9

—

(4035726)

1.24

0.20

2.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.20

0.0

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.6

—

(40761535) Cells panel - Urine sediment

1.19

0.20

3.5

3.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

657

1.21

0.19

4.5

4.0

1.6

1.4

mmol/l

0.95

602

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.25

0.18

1.2

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

0.73

0.17

1.0

1.3

—

350.6

—

(3003694) ABO and Rh group [Type] in Blood

169

1.16

0.16

1.6

1.3

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

314

0.88

0.16

3.2

3.9

21.9

22.0

0.01

138

(3007164) IgA [Mass/volume] in Serum or Plasma

123

1.17

0.13

1.1

1.3

2.8

2.4

g/l

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

239

0.89

0.12

3.9

3.5

—

(3042936) Bacteria identified in Isolate by Culture

1.17

0.11

1.8

2.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

277

0.91

0.10

5.4

4.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1.17

0.10

1.8

2.4

18.9

23.9

—

(3019060) Gas panel - Arterial blood

1.09

0.10

1.4

14.0

—

(40761511) CBC panel - Blood by Automated count

707

1.15

0.09

18.6

12.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

414

1.08

0.08

2.4

3.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

0.77

0.08

1.0

1.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

624

0.91

0.08

26.1

13.7

39.9

41.6

0.55

475

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.05

0.08

10.0

9.5

—

(3024731) MCV [Entitic volume]

752

0.97

0.08

35.8

19.1

90.4

90.8

0.41

740

(3000963) Hemoglobin [Mass/volume] in Blood

752

0.97

0.08

36.0

19.2

139.7

142.0

g/l

0.62

739

(3035941) MCH [Entitic mass]

752

0.97

0.08

35.7

19.0

30.2

30.5

0.62

740

(3026361) Erythrocytes [#/volume] in Blood

752

0.97

0.08

36.0

19.1

4.7

e12/l

0.10

730

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.07

0.08

1.6

1.8

—

(3044640) Blood type and Crossmatch panel - Blood

192

1.06

0.02

2.8

2.4

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

136

1.04

0.00

2.9

2.3

—

(3013512) EKG study

181

0.99

0.00

4.4

4.0

—

(3007461) Platelets [#/volume] in Blood

751

0.98

0.00

35.8

19.1

249.2

234.9

e9/l

1.28

730

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

0.00

0.0

1.8

—

33.3

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

0.0

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.00

0.0

1.3

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

0.00

0.0

1.2

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

0.00

0.0

2.4

—

119.3

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

4.4

—

147.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

0.00

0.0

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

2.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

0.00

0.0

2.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

0.0

1.4

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

0.00

0.0

1.5

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3042631) Mycobacterium sp identified in Specimen

0.00

0.0

4.9

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3045424) Erythrocytes [Presence] in Urine

0.00

0.0

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

0.00

0.0

1.0

—

(3044941) Cell count panel - Synovial fluid

0.00

0.0

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3004451) EKG impression Narrative

0.00

0.0

1.4

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

0.00

0.0

1.3

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.6

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

0.00

0.0

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

0.0

2.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

0.00

0.0

1.3

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.1

—

(3022145) Colonoscopy Study observation

0.96

0.00

1.0

1.3

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

0.00

0.0

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

0.00

0.0

4.6

—

63.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

2.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

0.00

0.0

1.2

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

1.6

—

13.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

2.8

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

2.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.0

1.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

0.00

0.0

2.2

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

13.9

—

(40761536) Microorganisms panel - Urine sediment

0.92

0.00

4.4

3.4

—

(4146454)

0.00

0.0

1.8

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(4306422)

0.00

0.0

1.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(4268621)

0.00

0.0

1.7

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

0.00

0.0

1.9

—

13.0

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

0.00

0.0

1.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

0.00

0.0

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

0.0

2.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SEXPREF and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SEXPREF.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SEXPREF – Disorders of sexual preference

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Disorders of sexual preference

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints